Nelfinavir, a Phase I/Phase II Rectal Cancer Study

Clinical trial NCT00704600 · COMPLETED

Trial details

NCT number: NCT00704600
Sponsor: Maastricht Radiation Oncology
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Colorectal Carcinoma Colorectal Tumors Neoplasms, Colorectal

Start date: 2008-09-01
Primary completion: 2010-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.